2024 annual financial data
Cumberland Pharmaceuticals Inc. 2024 Operating margin
Cumberland Pharmaceuticals Inc. 2024 operating margin with verified reported va…
Direct answer
Operating margin was -16.99%.
Operating income was -6,432,409 USD and net income was -6,479,770 USD.
Operating cash flow was -612,186 USD.
Get free Cumberland Pharmaceuticals Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 37,867,945 USD
- Operating income
- -6,432,409 USD
- Net income
- -6,479,770 USD
- Operating cash flow
- -612,186 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Cumberland Pharmaceuticals Inc. financial years